2 results match your criteria: "California (Dr Kownacki); University of Massachusetts Medical School[Affiliation]"
Using Electronic Health Records and Clinical Decision Support to Provide Return-to-Work Guidance for Primary Care Practitioners for Patients With Low Back Pain.
J Occup Environ Med
November 2017
From the Occupational and Environmental Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, NH (Dr McLellan); The Permanente Medical Group, San Francisco, California (Dr Kownacki); University of Massachusetts Medical School, Sudbury, Massachusetts (Dr Pransky; and ACOEM, Elk Grove Village, Illinois (Ms Dreger).
Objective: The aim of this study was to describe the process by which a group of subject matter experts in the area of return to work developed a resource tool to provide clinical decision support (CDS) for primary care clinicians.
Methods: A common musculoskeletal disorder, low back pain (LBP), was selected, pertinent literature reviewed, and specific recommendations for action in the clinical setting developed.
Results: Primary care practitioners (PCPs) are routinely expected to create work activity prescriptions.
Reducing Disability Durations and Medical Costs for Patients With a Carpal Tunnel Release Surgery Through the Use of Opioid Prescribing Guidelines.
J Occup Environ Med
December 2017
ReedGroup, Ltd., Westminster, Colorado (Dr Gaspar, Ms Zaidel); Kaiser Permanente, Oakland, California (Dr Kownacki, Dr Conlon); and Rocky Mountain Center for Occupational and Environmental Health, University of Utah, Salt Lake City, Utah (Dr Hegmann).
Objective: The impacts of compliance with opioid prescribing guidelines on disability durations and medical costs for carpal tunnel release (CTR) were examined.
Methods: Using a dataset of insured US employees, opioid prescriptions for 7840 short-term disability cases with a CTR procedure were identified. Opioids prescriptions were compared with the American College of Occupational and Environmental Medicine (ACOEM)'s opioid prescribing guidelines for postoperative, acute pain, which recommends no more than a 5-day supply, a maximum morphine equivalent dose of 50 mg/day, and only short-acting opioids.